-
Question
methodology
Publication: The Antagonistic Role of DHMEQ, an NF-κB Inhibitor, in Breast Cancer Progression
Are you considering analyzing members of the NF-κB related pathway, affected by DHMEQ? -
Question
qRT-PCR
Publication: The Antagonistic Role of DHMEQ, an NF-κB Inhibitor, in Breast Cancer Progression
Very interesting research! I wonder by which approach (Sybr or Taqman) you'll examine the NF-kB signaling. Also, which targets do you intend to test? Thanks!
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
